spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cytogenetics 

 HSMN NewsFeed - 22 Aug 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 21 Dec 2020
Astellas Reports XOSPATA(R) (gilteritinib) in Combination with Azacitidine Did Not Meet Endpoint of Overall Survival in Newly Diagnosed FLT3 Mutation-Positive Acute Myeloid Leukemia Patients Ineligible for Intensive Induction Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Oct 2015
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 21 Oct 2015
NeoGenomics signs Definitive Agreement to acquire Clarient, Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 14 Jul 2015
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
Diagnostics Product Launch
 HSMN NewsFeed - 29 May 2015
Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR(TM)
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 23 Apr 2015
NeoGenomics Announces Promotions
Diagnostics Oncology Personnel
 HSMN NewsFeed - 15 May 2014
John D. Thompson Joins Transgenomic's Board of Directors
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 18 Mar 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 21 Jan 2014
Affymetrix Receives FDA Clearance of First-of-its-kind Postnatal Test for Developmental Delays and Intellectual Disabilities in Children
Diagnostics FDA
 HSMN NewsFeed - 13 Sep 2012
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 24 Jul 2012
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
Diagnostics Cardiology Reimbursement
 HSMN NewsFeed - 18 Jul 2012
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE(TM) Cancer Profile Panels
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 20 Feb 2012
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
Diagnostics Oncology FDA
 HSMN NewsFeed - 27 Jan 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Diagnostics FDA
 HSMN NewsFeed - 30 Jun 2010
Eisai Announces Results of Phase III Study of Dacogen(R) (Decitabine) for Injection in Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2009
NeoGenomics Announces Executive Appointments
Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 Jul 2009
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 11 May 2009
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Diagnostics Neurology
 HSMN NewsFeed - 24 Oct 2008
Cancer Drug Vidaza(R) Receives Positive Opinion from European Regulatory Authority for Treatment of MDS and AML
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Jul 2008
The DNA Repair Company Strengthens Operations and Development Capabilities with Addition of Two Senior Officials
Oncology Personnel
 HSMN NewsFeed - 1 Jul 2008
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2008
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2007
China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer
Devices Personnel
 HSMN NewsFeed - 10 Oct 2007
Transgenomic Names New Sr. VP of Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 17 Sep 2007
Updated REVLIMID(R) Clinical Results Presented at the 12th International Workshop on Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Sep 2007
NCCN Updates Dermatofibrosarcoma Protuberans Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2007
Bioenvision Provides Evoltra(R) (clofarabine) Regulatory Update
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Jun 2007
Xanthus Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2007
Irvine Scientific Launches Their New SIS/AI Catheter
Devices FDA
 HSMN NewsFeed - 7 Feb 2007
Bioenvision Files with EMeA for Label Extension of Evoltra(R)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Jan 2007
NeoGenomics, Inc. Announces the Appointment of Robert J. Feeney, Ph.D. as Vice President of Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 11 Dec 2006
New Evoltra(R) Data Shows Impressive Response and Survival Rates
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2006
Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia
Diagnostics Oncology
 HSMN NewsFeed - 27 Nov 2006
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Sep 2006
US LABS / Esoterix Names Two Prominent Industry Medical Experts To Chief Diagnostic Consultant and Medical Director Positions
Diagnostics Personnel
 HSMN NewsFeed - 31 May 2006
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
cytogenetics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.